Form4insider filings, from the source

SEC Form 4 · accession 0000921895-17-001621

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
May 19, 2017
Accepted (ET)
May 23, 2017 · 6:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
9.00% Series A Cumulative Preferred StockF4,F2May 19, 2017J10,097$50.00A373,708IBy: Lone Star Value Investors, LP
Common StockF5,F6May 19, 2017M6,839—A27,066D
Common StockF1,F2holding———1,666,755IBy: Lone Star Value Investors, LP
Common StockF1,F3holding———83,308IBy: Separately Managed Account

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF5,F6—May 19, 2017M6,839A——Common Stock6,8390D

Explanation of responses